# AsiaBiome

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/asiabiome

- Industry: Biotechnology
- Headquarters: Hongkong, China
- Website: www.asiabiome.com
- Latest round: Seed (Aug 22, 2019)
- Investors on record: 1

## About

Founded in 2016 and based in Hong Kong, China, AsiaBiome operates as a biotechnology company that focuses on the development of microbiome-based therapeutics. In August 2019, AsiaBiome closed a seed funding from new investor 500 Startups.

AsiaBiome mainly engages in providing curing solutions of diseases such as IBS, Autism, ALS, and multiple sclerosis through the gut microbiome. The company involves the use of uniquely Asian microbes, which are gathered from a variety of healthy and patient populations across Asia. AsiaBiome utilizes advanced sequencing technology and proprietary analytics to identify key microbes responsible for various diseases. They also have exclusive access to the largest private stool bank in Asia, aiding them in identifying causal microbes in specific diseases.

The company generates revenue by providing curing solutions of diseases such as IBS, Autism, ALS, and multiple sclerosis.

## Funding rounds

- Seed, Aug 22, 2019 — 500 Global

## Investors

- 500 Global (https://capitalatlas.ai/funds/500-global) — Seed